Compounds > tadalafil
Page last updated: 2024-09-02

tadalafil and Kidney Diseases

tadalafil has been researched along with Kidney Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Abd Elkadir, A; Armaly, Z; Artol, S; Farah, R; Ghattas, N; Habashi, N; Jabbour, AR; Kinaneh, S; Nseir, W; Saffouri, A1
Albulescu, D; Buga, AM; Burada, F; Calina, D; Ciurea, ME; Docea, AO; Iordache, AM; Mamoulakis, C; Mitrut, R; Rogoveanu, OC; Sosoi, S; Tsatsakis, A; Vasile, RC; Zlatian, O1
Albulescu, D; Buga, AM; Calina, D; Docea, AO; Georgiadis, G; Iordache, AM; Mamoulakis, C; Mitrut, R; Tsatsakis, A; Vasile, RC; Zisis, IE1
Best, SL; Cadeddu, JA; Faddegon, S; Mir, SA; Olweny, EO; Park, SK; Tan, YK1
Bedding, AW; Forgue, ST; Jewell, H; Mitchell, MI; Patterson, BE; Payne, CD; Phillips, DL; Wrishko, RE1

Trials

1 trial(s) available for tadalafil and Kidney Diseases

ArticleYear
Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients.
    Renal failure, 2019, Volume: 41, Issue:1

    Topics: Aged; Carnitine; Cross-Over Studies; Female; Haptoglobins; Humans; Kidney Diseases; Male; Phosphodiesterase 5 Inhibitors; Prospective Studies; Renal Insufficiency, Chronic; Tadalafil

2019

Other Studies

4 other study(ies) available for tadalafil and Kidney Diseases

ArticleYear
Sildenafil and tadalafil reduce the risk of contrast-induced nephropathy by modulating the oxidant/antioxidant balance in a murine model.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2020, Volume: 135

    Topics: Acetylcysteine; Animals; Antioxidants; Catalase; Contrast Media; Disease Models, Animal; Glutathione; Kidney Diseases; Male; Mice; Oxidants; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Rats; Rats, Wistar; Sildenafil Citrate; Tadalafil; Thiobarbituric Acid Reactive Substances

2020
Phosphodiesterase-5 inhibitors ameliorate structural kidney damage in a rat model of contrast-induced nephropathy.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2020, Volume: 143

    Topics: Animals; Contrast Media; Kidney Diseases; Kidney Tubules; Male; Phosphodiesterase 5 Inhibitors; Rats; Rats, Wistar; Sildenafil Citrate; Tadalafil

2020
Tadalafil for prevention of renal dysfunction secondary to renal ischemia.
    The Canadian journal of urology, 2012, Volume: 19, Issue:3

    Topics: Animals; Carbolines; Creatinine; Female; Ischemia; Kidney; Kidney Diseases; Phosphodiesterase 5 Inhibitors; Random Allocation; Reperfusion Injury; Statistics, Nonparametric; Swine; Tadalafil

2012
Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics.
    British journal of clinical pharmacology, 2007, Volume: 63, Issue:1

    Topics: Adult; Age Factors; Belgium; Carbolines; Diabetes Mellitus; Erectile Dysfunction; Female; Germany; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Phosphodiesterase Inhibitors; Poland; Sex Factors; Tadalafil; United Kingdom

2007